New technology from CODEX-DNA, now in Finland exclusively from Immuno Diagnostic Oy. Codex-DNA’s key product is the BioXP “DNA-printer” which enables you to produce DNA fast & safely in your own lab. IP protected – Your vectors never leave your lab! Watch the short video to learn more:
Dan Gibson, the inventor of the Gibson assembly cloning technique works as Chief Technology Officer at Codex-DNA. Watch his TED talk where he introduces the world’s first and only automated platform for personalized medicine and distributed vaccine manufacturing.
Codex-DNA BioXp3250
- The first and only push-button automated platform for building libraries, fragments, and clones up to 32 complex constructs overnight
- Main application areas: Basic research, Vaccine development, Cloning, Immunotherapy, Personalized Medicine, Drug Development, Protein production, Enzyme Engineering
- Provides over 10 μg of transfection-ready DNA output overnight
- The instrument allows you to automate the process of gene synthesis, modification and amplification – here we can go from months of research to days in finding suitable clonal candidates for e.g. possible vaccines
- The highest quality gene fragments: proprietary two-step process results in error rates between 1:10,000 and 1:30,000
- Reagents are centered around Vaccine Development – including Full Length Genomes of the COVID-19 Virus and RNA Controls for SARS
- Also, Codex-DNA is a specialist in cloning and amplification with Gibson Assembly
- In addition, the company manufactures VMAX reagents that are alternatives to E. Coli media that can generate x4 more protein output for growth
How it works:
